Literature DB >> 12419588

Cell proliferation, nuclear ploidy, and EGFr and HER2/neu tyrosine kinase oncoproteins in infiltrating ductal breast carcinoma.

J F Fernández Val1, J Losada, M A Arregui Murua, R Sarría.   

Abstract

The purpose of this work was to study if the variations in the nuclear DNA content and the expression of EGFr and HER2/neu transmembrane oncoproteins were related and if this influences the rate of cell proliferation modifying, in each case, the potential aggressivity of the neoplasia. Thirty-four ductal breast carcinoma tissue samples of tumors of up to 2 cm in diameter were analyzed by flow cytometry. HER2/neu and EGFr were measured by immunohistochemical methods. Twenty cases were diploid (DNA index of 1) and 14 cases were aneuploid (DNA index other than 1). The expression of EGFr and HER2/neu was significantly higher in aneuploid tumors compared with diploid tumors. The cell proliferation rate was significantly higher in tumors with an aneuploid pattern. The expression of EGFr was associated with a higher rate of cell proliferation. The higher expression of EGFr and HER 2/neu oncoproteins in aneuploid tumors suggests that the increased proliferative activity of aneuploid carcinomas is influenced by the activity of such oncoproteins, which favors a more aggressive biological behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419588     DOI: 10.1016/s0165-4608(02)00567-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.

Authors:  Dolores Subirá; Cristina Serrano; Susana Castañón; Raquel Gonzalo; Julia Illán; Javier Pardo; María Martínez-García; Esther Millastre; Francisco Aparisi; Miguel Navarro; Manuel Dómine; Ignacio Gil-Bazo; Pedro Pérez Segura; Miguel Gil; Jordi Bruna
Journal:  Neuro Oncol       Date:  2011-10-12       Impact factor: 12.300

2.  Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.

Authors:  Ji-Young Jang; Yoon-Kyung Jeon; Chul-Woo Kim
Journal:  BMC Cancer       Date:  2010-07-23       Impact factor: 4.430

3.  Immunohistochemical characterization of subtypes of male breast carcinoma.

Authors:  Yimin Ge; Nour Sneige; Mahmoud A Eltorky; Zhiqin Wang; E Lin; Yun Gong; Ming Guo
Journal:  Breast Cancer Res       Date:  2009-05-14       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.